Abivax

France


 
Quantité totale PI 113
Rang # Quantité totale PI 11 555
Note d'activité PI 2,7/5.0    63
Rang # Activité PI 11 393
Symbole boursier
ISIN FR0012333284
Capitalisation 505.4M  (EUR)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

46 2
31 2
28 2
2
 
Dernier brevet 2025 - Obefazimod for treatment of ulce...
Premier brevet 2008 - Methods of enhancing adjuvaticit...
Dernière marque 2022 - ABIVAX
Première marque 2015 - ABIVAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a...
Invention Obefazimod for treatment of ulcerative colitis. The present invention relates to Obefazimod or a ...
Invention Phenyl-n-quinoline derivatives for treating a rna virus infection. A compound of formula (I) or ...
Invention Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging. The manuf...
2022 Invention Method of preparation of 1-(n-(quinolin-2-yl)- (phenylamino)-1-deoxy-beta-d-glucopyranuronic acid...
Invention Method of preparation of 1-(n-(quinolin-2-yl)- (phenylamino)-1-deoxy-βeta-d-glucopyranuronic acid...
P/S Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammato...
P/S Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammat...
Invention In vitro or ex vivo methods for screening a quinoline derivative. In vitro or ex vivo methods for...
P/S Pharmaceutical research and development; drug development and discovery services; medical and sci...
Invention Preparation method of quinoline derivative compounds. A method for preparing a compound of formu...
Invention Preparation method of quinoline derivative compounds. The present invention relates to a method f...
2021 Invention Combinations including abx196 for the treatment of cancer. An antitumor pharmaceutical combinatio...
Invention Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing t...
Invention Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The prese...
Invention Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. Co-crystals an...
Invention Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The present inv...
Invention Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The presen...
2020 Invention Use of quinoline derivatives for the treatment of inflammatory diseases. The present disclosure r...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (I) is: A co...
Invention Aryl-n-aryl derivatives for treating an rna virus infection. The present invention relates to a c...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. The present invention relates to a co...
Invention Compounds useful for treating cancer. A compound of formula (I): 7 together with the nitrogen at...
Invention Compounds and pharmaceutical compositions containing at least one of the compounds. The present d...
2019 Invention Biomarkers, and uses in treatment of viral infections, inflammations, or cancer. Biomarkers and ...
Invention Quinoline derivatives for use in the treatment or prevention of cancer. A compound of formula (I...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. A compound of Formula (I...
Invention Biomarkers, and uses in treatment of viral infections, inflammations, or cancer. The present disc...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. The present disclosure r...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. 131336212141212121111122...
Invention Quinoline derivatives for use in the treatment or prevention of cancer. The present invention con...
Invention Quinoline derivatives for use in the treatment or prevention of cancer. 1313362121412121211111221...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (Ic) A compo...
Invention Phenyl-n-quinoline derivatives for treating a rna virus infection. A compound of formula (I) or a...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound: 4)alkyl group, by a cycl...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (Ie): A comp...
Invention Aryl-n-ayrl derivatives for treating an rna virus infection. The present invention relates to a c...
Invention Phenyl/pyridyl-n-phenyl/pyridyl derivatives for treating rna virus infection. The present inventi...
Invention Phenyl/pyridyl-n-phenyl/pyridyl derivatives for treating a rna virus infection. The present inven...
Invention Phenyl-n-quinoline derivatives for treating an rna virus infection. The present invention relates...
2018 Invention Abx196 for use in the treatment of bladder cancer. The compound ABX196 and pharmaceutical composi...
2015 P/S Adjuvants à usage vaccinal, vaccins à usage humain, vaccins pour humains administrés par voie ora...
P/S Adjuvants for use as vaccines, preparations for vaccines for human use; preparations for vaccine...
P/S Adjuvants for use with vaccines; human vaccines preparations; oral vaccine preparations; pharmace...